「antagonist」の共起表現(1語右で並び替え)

「antagonist」の共起表現一覧(1語右で並び替え)

antagonist

1 2 3 次へ＞

1語右で並び替え

該当件数:560件

a human sized (and bi-pedal) beaver; and the antagonist, a gay vampire called "Dragula" instead of "
The film's title refers to its primary antagonist: a parasitic extraterrestrial lifeform that
dipine is a calcium channel blocker (calcium antagonist), a drug used to control hypertension (high
The main antagonist, a Dream Demon who looks like a knight weari
Clinidipine is the new type of calcium antagonist accompanied with L-type and N-type calcium c
c acid) is a selective NMDA receptor (NMDAR) antagonist acting at the glycine site on the NMDAR comp
ve additional mechanisms of action including antagonist action at nicotinic acetylcholine receptors,
n tissues where coactivators predominate and antagonist activity where corepressors are in excess.
Propiram exhibits weak opioid antagonist activity on the mu receptor -- quite a bit w
Butorphanol exhibits partial agonist and antagonist activity at the μ opioid receptor and agonis
ceptor modulators may also have more or less antagonist activity.
s may be related to its weak β1-adrenoceptor antagonist activity.
, South Carolina, with a view to drawing his antagonist after him to the points where he was the yea
series) became a traitor and the film's main antagonist after finally becoming disillusioned with hi
ination of BW-723C86 with a selective 5-HT2C antagonist allows 5-HT2B mediated responses to be studi
rtial mu opioid receptor agonist and weak mu antagonist analgesic from the ampromide family of drugs
rs developed naltrindole to be a non-peptide antagonist analog of the delta-preferring endogenous op
It acts as a competitive GABAA receptor antagonist and also inhibits glycine receptors with sim
time, he appeared in dual roles, as both the antagonist and protagonist.
dextromethorphan, is a common NMDA receptor antagonist and pro-drug to dextrorphan.
nese literature, Tong Guan is featured as an antagonist and enemy of the 108 Liangshan outlaws.
is a competitive, dual OX1 and OX2 receptor antagonist and selectively inhibits the functional cons
It is a non-competitive NMDA antagonist and calcium channel blocker
search which acts as a selective D1 receptor antagonist and D5 receptor full agonist, as evidenced b
It acts as an α1-adrenoceptor antagonist and as an 5-HT1A receptor agonist Although a
t was initially classified as a selective H3 antagonist, and seemed to be well tolerated during earl
ynthetic compound that acts as a D1 receptor antagonist and has either minimal or negligible effects
It is a serotonin antagonist and histamine antagonist.
as a selective α3β4 nicotinic acetylcholine antagonist, and is even more selective than 18-MC with
The main antagonist and Kyosuke's father.
effects, which acts as both a sigma receptor antagonist, and a 5-HT1A agonist.
pride acts as a selective D2 and D3 receptor antagonist and also has high affinity for the sigma rec
hrine reuptake inhibitor, serotonin receptor antagonist, and H1 receptor antagonist, among other pro
of receptor systems, being both a weak NMDA antagonist and a 5HT1A agonist.
It is much more potent an antagonist, and more selective for the CB1 receptor ove
nt cannabinoid CB1 receptor inverse agonist ( antagonist) and blocks the effect of anandamide in kera
t acts as a 5-HT2 and α1-adrenergic receptor antagonist, and has also been shown to inhibit the reup
It also functions as a 5-HT2B antagonist and has some affinity for the 5-HT2A and 5-H
e (NPS-1506) is a drug which acts as an NMDA antagonist and a serotonin reuptake inhibitor, and has
related to memantine, which acts as an NMDA antagonist and has neuroprotective effects.
Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonis
- A dissociative hallucinogen (NMDA receptor antagonist) and cough suppressant.
s as both a selective α2 adrenergic receptor antagonist, and an antagonist for the imidazoline recep
m channel blocker, competitive AMPA receptor antagonist, and non-competitive NMDA receptor antagonis
r agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist.
dolol which acts as both a β1 adrenoreceptor antagonist and a 5-HT1A receptor antagonist.
in according to one source), 5-HT2C receptor antagonist, and 5-HT3 receptor antagonist.
her, starring Michael Fassbender as the main antagonist and written by Dave Kajganich.
ney Todd legend, Todd himself is the primary antagonist, and no character equivalent to Judge Turpin
citonin gene-related peptide receptor (CRLR) antagonist and blocks this peptide.
ent and more selective than MPEP as a mGluR5 antagonist, and produces similar neuroprotective, antid
as a 5-HT1A, 5-HT2A, 5-HT7, and D2 receptor antagonist, and has been used to identify these recepto
18-MC is a selective α3β4 nicotinic antagonist and, in contrast to ibogaine, has no affinit
After antagonist Andross launches an attack against the plane
nonselective adenosine receptor antagonist, antagonizing A1, A2, and A3 receptors almos
Another CRH-1 antagonist antalarmin has been researched in animal stu
ucted before the development of modern 5-HT3 antagonist anti-emetics such as ondansetron, revealed t
It is a second-generation H1-receptor antagonist antihistamine and works by blocking Histamin
Consequently unlike the H1 antagonist antihistamines which are sedating, H3 antago
In 2003, the first NK1 receptor antagonist, aprepitant (Emend), received marketing appr
inephrine reuptake inhibitor and H1 receptor antagonist, as well as a very weak α1-adrenergic recept
n agonist at (α4)2(β2)3 pentamers, but as an antagonist at (α4)3(β2)2 pentamers.
Bilobalide has recently been found to be an antagonist at the GABAA and GABAA-rho receptors.
ticals, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor, with a 5-H
ors, but this drug is both an agonist and an antagonist at D2 receptors.
scovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with aroun
L-46470) is a drug which acts as a selective antagonist at the serotonin 5-HT3 receptor.
e parasympathetic nervous system but acts as antagonist at the nicotinic acetylcholine receptors at
clane (EGIS-3886) is a drug which acts as an antagonist at the 5-HT2A receptor, as an inverse agonis
HT1A somatodendritic autoreceptors but as an antagonist at postsynaptic 5-HT1A receptors.
iazine derivative which acts as an histamine antagonist at the H1 subtype.
Nefazodone acts primarily as a potent antagonist at the 5-HT2A receptors (Kd 26 nM).
Flupentixol acts as an antagonist at various dopamine (D1-D5), serotonin (5-HT
used in scientific research which acts as an antagonist at GABAB receptors.
synthetic compound that acts as a selective antagonist at the dopamine receptor subtypes D2 and D3,
ble affinity for other receptors; acts as an antagonist at D1 but as an agonist at D5
s an agonist at the D2 dopamine receptor and antagonist at the α1 adrenergic receptor.
is a long-acting (6 to 8 hr), noncompetitive antagonist at the AT1 receptor, and contributes to the
t at the α2 and α3 subtypes, but as a silent antagonist at α1 and α5 subtypes.
Meclozine is an antagonist at H1 receptors.
ak partial agonist at the D3 subtype, and an antagonist at D2Sh autoreceptors on dopaminergic nerve
UR-AK49 is a pure antagonist at Y4 with no partial agonist effects, and a
e agonist for the M1 and M4 subtypes, yet an antagonist at the M2, M3 and M5 subtypes.
drug which acts as a selective, non-peptide antagonist at the neuropeptide S receptor NPSR.
Propiomazine is an antagonist at types 1, 2, and 4 dopamine receptors, ser
iroxatrine is drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adre
0.68nM respectively, but interestingly is an antagonist at GPR55, the putative "CB3" receptor.
at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.
-127,935 is a drug which acts as a selective antagonist at the serotonin receptors 5-HT1B and 5-HT1D
PEAQX is a competitive antagonist at the NMDA receptor.
a drug which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor, with aroun
Istradefylline (KW-6002) is an antagonist at the A2A receptor.
t at the dopamine receptor D2, as well as an antagonist at the related D3 subtype, but with good sel
for the α2C subtype, as well as being a weak antagonist at the α2A and α2B subtypes.
for alpha-2 receptors and a medium affinity antagonist at the 5-HT1a receptor.
It acts as an antagonist at all of these sites.
tron (LY-277,359) is a drug which acts as an antagonist at the 5HT3 receptor It is orally active and
c aryl derivative that acts as a competitive antagonist at the CB2 cannabinoid receptor.
phenylbutylpiperazine class which acts as an antagonist at the 5-HT2A receptor.
at nicotinic acetylcholine receptors and an antagonist at μ-opioid receptors.
etron (F-0930-RS) is a drug which acts as an antagonist at the 5HT3 receptor It is a potent antiemet
(RP-62204) is a drug which acts as a potent antagonist at both the 5HT2A receptor, and the Dopamine
ceptor, but whether it acts as an agonist or antagonist at this site is unknown.
Sulpiride is a selective antagonist at dopamine D2 and D3 receptors.
Zacopride is a potent antagonist at the 5HT3 receptor and an agonist at the 5
Etoperidone acts as an antagonist at a number of receptors in the following or
Studies show that scoulerine is an antagonist at the α2-adrenoceptor, α1D-adrenoceptor and
research, which is a selective, non-peptide antagonist at the melanin concentrating hormone recepto
er THC-C4 is an agonist, partial agonist, or antagonist at the cannabinoid receptors.
a drug which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor, with good
ally developed by Eli Lilly which acts as an antagonist at the AMPA and kainate families of ionotrop
research, which is a selective, non-peptide antagonist at the melanin concentrating hormone recepto
tron (MDL-72,222) is a drug which acts as an antagonist at the 5HT3 receptor.
n as methiothepin, is a drug that acts as an antagonist at various serotonin and dopamine receptors.
ring his final fight against the show's main antagonist Babalun and the Sekishin Gaia (First display
The development of a muscarinic antagonist based on Himbacine failed but an analog is n
an not easily be classified as an agonist or antagonist, because it can be a little of both, dependi
: Ultraman Taro has a one-on-one battle with antagonist Belial in space.
ive drug structurally derived from the GABAA antagonist bicuculline.
(SL-82.0715) is a drug which acts as an NMDA antagonist, binding to the polyamine modulatory site.
(GV-150,526) is a drug which acts as an NMDA antagonist, binding selectively to the glycine site on
o the VEGF Receptor 2 it works as a receptor antagonist blocking the binding of vascular endothelial
bustly increases Arc levels while H89, a PKA antagonist, blocks these effects as does further downst
n with the non-selective endothelia receptor antagonist bosentan.
rphan is a non-selective opioid which is a μ antagonist but a κ partial agonist.
lieved to act as a selective 5-HT1A receptor antagonist, but a subsequent discovery showed that it a
nique pharmacodynamics: it is a selective β1 antagonist, but a β2 partial agonist.
It acts as an NMDA receptor antagonist but has low potency and acts mainly as a pro
SR 59230A was thought to be a selective β3 antagonist but later found to also be an antagonist of
Azaperone acts primarily as a dopamine antagonist but also has some antihistaminic and anticho
ncestral ranch have fallen into the hands of antagonist, Cale Chason.
It is utilized by movie and timeline antagonist Char Aznable.
rs are represented with green dots while the antagonist characters are represented with brown dots.
an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection
ride is the azide derivative of the dopamine antagonist clebopride.
s is demonstrated by the effects of agonist/ antagonist combinations on the desensitization of recep
nts, Valentine Morgenstern, the series' main antagonist, comes from the Morgenstern family whose emb
is a novel, long-acting, inhaled muscarinic antagonist currently being developed as a maintenance t
ed Sil-an-set-ron) is a drug that is a 5HT-3 antagonist currently under trial phase in the EU and US
e progestagen chlormadinone and the androgen antagonist cyproterone.
Lupitidine is an H2 receptor antagonist described as an antiulcer agent.
of a new generation of cannabinoid receptor antagonist designed to avoid the central nervous system
It was the first non-peptide antagonist developed for the Y1 receptor and has been w
tant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being
ofran in most countries) was the first 5-HT3 antagonist, developed by Glaxo around 1984.
29 is a drug which was the first non-peptide antagonist developed that is selective for the orexin r
a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing
It was the first non-peptide NK3 antagonist developed in the mid-1990s, and has still no
67 is a drug which was the first non-peptide antagonist developed that is selective for the orexin r
n is higher the equilibrium is driven in the antagonist direction.
) is a drug which acts as a competitive NMDA antagonist, directly competing with glutamate for bindi
/GABAB agonists along with a selective GABAB antagonist, do not produce a sedative effect, instead c
of Sonic the Hedgehog, created by the series antagonist Dr. Robotnik, and is able to match Sonic's e
See also: 5-HT3 receptor antagonist: Drug discovery and development
is the "unnatural" enantiomer of the opioid antagonist drug (-)-naloxone.
9,897 is a potent and selective NK2 receptor antagonist drug.
antalarmin itself, or more likely newer CRF antagonist drugs still under development, could be usef
nt pathway to conventional dopamine or 5HT2A antagonist drugs and may have a more favourable side ef
Several opioid antagonist drugs were found to act as antagonists for T
at is wrong, the team treat Alex with opioid antagonist drugs and induce a coma in order to relieve
Fonseca supplied the voice of Albina, the antagonist during the first third of the film.
R's antagonist, Dyuminas, is more humanized and less condes
Naloxazone produces very long lasting antagonist effects as it forms a covalent bond to the a
ot cross the blood-brain barrier, and so has antagonist effects throughout the body, counteracting e
gue of spiperone, and also has some dopamine antagonist effects.
e speeches from The Fountainhead: one by the antagonist Ellsworth Toohey, one which is actually more
discovered Diovan, the second angiotensin II antagonist ever to be marketed.
eased glucose metabolism in response to NMDA antagonist exposure.
y could be a more flexible antidote than the antagonist flumazenil which is commonly used to treat b
oxine are not reversed by the benzodiazepine antagonist flumazenil.
razol, and the benzodiazepine GABAA receptor antagonist Flumazenil.
He returns as the main antagonist for the series one finale when he attempts a
scientific research that acts as a selective antagonist for the metabotropic glutamate receptor subt
L-15,572 is a drug which acts as a selective antagonist for the serotonin receptor subtype 5-HT1D, w
eptor ligand which is a potent and selective antagonist for the nociceptin receptor (ORL-1), several
Diprenorphine is considered the specific antagonist for etorphine and carfentanil, and is normal
JTC-801 is a selective antagonist for the nociceptin receptor, also known as t
It acts as a selective antagonist for the α2B adrenergic receptor, and has bee
It acts as a noncompetitive antagonist for the GABAA receptor chloride channels.
esearch which acts as a potent and selective antagonist for the Neuropeptide Y receptor Y2.
irst compound found to be a highly selective antagonist for the nociceptin receptor, also known as t
clofen, or phosphonobaclofen, is a selective antagonist for the GABAB receptor.
mosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.
Andrew Jacobs, "A New Antagonist for AIDS", New York Times, 1 Dec 1996, acces
n scientific research which acts as a potent antagonist for the Neuropeptide Y / Pancreatic polypept
It acts as a selective antagonist for the cholecystokinin receptor CCKA, and h
by GlaxoSmithKline which acts as a selective antagonist for the NK1 receptor.
as an orally active, non-peptide, selective antagonist for the NK1 receptor, binding with a Ki of 0
c research, acting as a potent and selective antagonist for both the 5-HT6 and 5-HT7 serotonin recep
Naltriben is a potent and selective antagonist for the delta opioid receptor, which is used
a drug which acts as a potent and selective antagonist for the Alpha-1 adrenergic receptor subtype
He is the main antagonist for the first three episodes.
amol also acts as a low to moderate affinity antagonist for the D2, 5-HT2, H1, H2, and muscarinic ac
SDZ SER-082 is a drug which acts as a mixed antagonist for the 5-HT2B and 5-HT2C serotonin receptor
cientific research which acts as a selective antagonist for the α2A adrenoreceptor.
which acts as a potent and highly selective antagonist for the Neuropeptide Y receptor Y5, with a K
research chemical which acts as a selective antagonist for the 5HT2C receptor.
rst compound developed to act as a selective antagonist for the serotonin receptor 5-HT5A, with sele

1 2 3 次へ＞